Patients
Consecutive patients with pancreatic masses undergoing CH‐EUS examinations (followed by EUS‐FNA) in the Department of Gastroenterology, The Third Xiangya Hospital of Central South University, China between January and February 2020 were recruited to the study. All patients were followed up for at least 8 months.